Runcaciguat
CAS No. 1402936-61-1
Runcaciguat ( —— )
Catalog No. M26816 CAS No. 1402936-61-1
Runcaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 222 | Get Quote |
|
10MG | 402 | Get Quote |
|
25MG | 665 | Get Quote |
|
50MG | 888 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRuncaciguat
-
NoteResearch use only, not for human use.
-
Brief DescriptionRuncaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
-
DescriptionRuncaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptormGluR1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1402936-61-1
-
Formula Weight488.3
-
Molecular FormulaC23H22Cl2F3NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]([C@@H](C)C(F)(F)F)(C(=O)Nc1cc(ccc1Cl)[C@@H](CC(O)=O)C1CC1)c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yu SP, Sensi SL, et al. Membrane-delimited modulation of NMDA currents by metabotropic glutamate receptor subtypes 1/5 in cultured mouse cortical neurons. J Physiol. 1997 Mar 15;499 ( Pt 3)(Pt 3):721-32.
molnova catalog
related products
-
Mc-Val-Cit-PAB-Cl
Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE.
-
C-Reactive Protein (...
CRP, an acute phase serum protein synthesized in response to inflammatory cytokines, produces antitumor effects in animals. The fragment CRP (174-185) (RS-83277) shows similar activity by significantly enhancing the tumoricidal activity of human monocytes and alveolar macrophages in vitro.
-
Transdermal Peptide ...
Transdermal Peptide TFA (TD 1 Peptide TFA) is an 11-amino acid polypeptide that binds to Na+/K+ -atpase beta-subunit (ATP1B1) and interacts with the C terminal of ATP1B1.Transdermal Peptide TFA can enhance the transmission of some large molecules in the skin.